Medical digital imaging leader displays strongest growth in company history, sees customers growing quickly as well
STOCKHOLM – February 18, 2016 – ContextVision, the leader in medical image enhancement technology, reported total sales of 8.5 million USD in 2015 – the highest sales year in the company’s history. This milestone for the imaging technology leader is a result of successful partnerships with OEM customers worldwide. The customization of the image enhancement software ensures optimal image quality, meeting the increasing demand for superior medical imaging in healthcare.
ContextVision’s provides medical imaging software for 2D/3D/4D Ultrasound, MRI, X-ray and Mammography to a global customer base. With state-of-the art, versatile image enhancement software, ContextVision ensures the highest quality imaging and diagnostic confidence across modalities. The company’s record sales ring positive for customers looking for continued, unsurpassed image quality.
“Over the course of the past year, we have continued to develop our partnerships and increased our customer base, serving the ever evolving needs of the medical imaging industry,” said Fredrik Palm, vice president, ContextVision. “Our mission is to drive innovation in medical imaging to deliver the highest quality imaging solutions, and we anticipate continued success going forward.”
About ContextVision
ContextVision’s cutting-edge technology helps doctors more accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, the company’s state-of-the-art medical image analysis and enhancement software for 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography is used by leading equipment manufacturers worldwide. ContextVision continues to invest heavily in R&D in order to expand its technology platform. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV.
Media Contact
Fredrik Palm
Vice President
Phone: +46 76 870 25 43
Operator: +46 8 750 35 50
E-mail: